{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = 3-(3,4-Dichlorophenyl)-2-(dimethylamino)-2-methylpropan-1-ol
| image = Cericlamine.svg
| width = 

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration = [[Oral administration|Oral]]<ref name="DarcourtTessera1992">{{cite journal|last1=Darcourt|first1=G.|last2=Tessera|first2=M.|last3=Lesaunier|first3=R.|last4=Engrand|first4=P.|last5=Scherrer|first5=B.|last6=Dreyfus|first6=J. F.|last7=Bogaievsky|first7=Y.|title=A MULTICENTRE DOUBLE-BLIND, PLACEBO-CONTROLLED DOSE-FINDING STUDY WITH CERICLAMINE IN MAJOR DEPRESSION.|journal=Clinical Neuropharmacology|volume=15|year=1992|pages=176B|issn=0362-5664|doi=10.1097/00002826-199202001-00339}}</ref>

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 8 hours<ref name="DarcourtTessera1992" />
| excretion =

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 112922-55-1
| CAS_supplemental = 
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = VES82D23IB
| ATC_prefix = None
| ATC_suffix = 
| PubChem = 131074
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 115890

<!--Chemical data-->
| C=12 | H=17 | Cl=2 | N=1 | O=1
| molecular_weight = 262.17548 g/mol
| smiles = CC(CC1=CC(=C(C=C1)Cl)Cl)(CO)N(C)C
| StdInChI = 1S/C12H17Cl2NO/c1-12(8-16,15(2)3)7-9-4-5-10(13)11(14)6-9/h4-6,16H,7-8H2,1-3H3
| StdInChIKey = FWYRGHMKHZXXQX-UHFFFAOYSA-N
| synonyms = 
}}

'''Cericlamine''' ([[International Nonproprietary Name|INN]]) (developmental code name '''JO-1017''') is a potent and moderately [[selective serotonin reuptake inhibitor]] (SSRI) of the [[substituted amphetamine|amphetamine]] family (specifically, a [[chemical derivative|derivative]] of [[phentermine]], and closely related to [[chlorphentermine]], a highly selective [[serotonin releasing agent]]) that was investigated as an [[antidepressant]] for the treatment of [[depression (mood)|depression]], [[anxiety disorder]]s, and [[anorexia nervosa]] by [[Jouveinal SA|Jouveinal]] but did not complete development and was never marketed.<ref name="DarcourtTessera1992" /><ref name="CrowBrown2003">{{cite journal|last1=Crow|first1=Scott|last2=Brown|first2=Eric|title=Investigational drugs for eating disorders|journal=Expert Opinion on Investigational Drugs|volume=12|issue=3|year=2003|pages=491–499|issn=1354-3784|doi=10.1517/13543784.12.3.491}}</ref><ref name="Patel2000">{{cite book|author=Ramesh N. Patel|title=Stereoselective Biocatalysis|url=https://books.google.com/books?id=QwgCzKDfNAoC&pg=PA48|date=3 January 2000|publisher=CRC Press|isbn=978-0-8247-8282-5|pages=48–}}</ref><ref name="TangTang2012">{{cite book|author1=Lily C. Tang|author2=Stephen J. Tang|title=Neurochemistry in Clinical Application|url=https://books.google.com/books?id=d2DlBwAAQBAJ&pg=PA81|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-1-4615-1857-0|pages=81–}}</ref> It reached [[Phases of clinical research#Phase III|phase III]] [[clinical trial]]s in 1996 before development was discontinued in 1999.<ref name="AdisInsight">{{cite web | title = Cericlamine | author = AdisInsight | accessdate = 13 January 2016 | url = http://adisinsight.springer.com/drugs/800001340}}</ref>

==Synthesis==
[[File:Cericlamine synthesis.png|thumb|left|700px|Cericlamine synthesis:<ref>{{US patent|6121491}}</ref>]]{{clear left}}
Arylation of [[methacrylic acid]] with a diazonium salt of [[3,4-dichloroaniline]] (or 3,4-dichloro-benzenediazonium salt), is carried out according to the [[Meerwein reaction]] catalysed by a metallic halide. For the next step, the halide is displaced by dimethylamine, then esterification is performed, followed by reduction with a metal hydride.

==See also==
{{Colbegin}}
* [[3,4-Dichloroamphetamine]]
* [[Alaproclate]]
* [[Bupropion]]
* [[Chlorphentermine]]
* [[Clortermine]]
* [[Cloforex]]
* [[Etolorex]]
* [[Femoxetine]]
* [[Ifoxetine]]
* [[Indalpine]]
* [[Methylenedioxyphentermine]]
* [[Omiloxetine]]
* [[Panuramine]]
* [[Parachloroamphetamine|''para''-Chloroamphetamine]]
* [[para-Chloromethamphetamine|''para''-Chloromethamphetamine]]
* [[Phentermine]]
* [[Pirandamine]]
* [[Seproxetine]]
* [[Viqualine]]
* [[Zimelidine]]
{{Colend}}

==References==
{{Reflist|2}}

{{Monoamine reuptake inhibitors}}
{{Phenethylamines}}

[[Category:Amines]]
[[Category:Antidepressants]]
[[Category:Chloroarenes]]
[[Category:Phenethylamines]]
[[Category:Selective serotonin reuptake inhibitors]]
[[Category:Substituted amphetamines]]

{{nervous-system-drug-stub}}